Article Detail - JE Part B
Revision(s) for MolDX Billing and Coding Articles - Effective January 1, 2021
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
|Medicare Coverage Database Number||Billing and Coding Article Title and Revision Number|
|A57509||MolDX: Prolaris™ Prostate Cancer Genomic Assay - R2|
|A57514||MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease - R1|
|A57372||MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease - R1|
Effective Date: January 01, 2021
Summary of Article Changes:
Addition of Code to Group I:
0228U: ONCOLOGY (PROSTATE), MULTIANALYTE MOLECULAR PROFILE BY PHOTOMETRIC DETECTION OF MACROMOLECULES ADSORBED ON NANOSPONGE ARRAY SLIDES WITH MACHINE LEARNING, UTILIZING FIRST MORNING VOIDED URINE, ALGORITHM REPORTED AS LIKELIHOOD OF PROSTATE CANCER
Visit the Molecular Diagnostic Services (MolDX) webpage to access the locally hosted MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of locally hosted coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Thu, 11 Feb 2021 15:45:59 +0000